The aims of the 340B program are important. But, unfortunately, there is little evidence that the program is delivering on ...

Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Johnson & Johnson is escalating its fight with the federal government over its controversial plan to change how it doles out ...

Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we ...

Johnson and Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and ...

Discover how the 340B drug pricing program, intended to help low-income patients, has become a system of abuse and misuse ...

California is poised to pass a ballot measure aimed at imposing 340B spending restrictions for certain healthcare entities participating in the ...